Ro and LillyDirect aren't really competitors on medication price — Ro's Zepbound vials are sold through the same LillyDirect self-pay channel at the same base price. The real choice is whether you need a prescriber and support layered on top.
If you already have a doctor and just want the lowest ongoing cost, going directly through LillyDirect (or a flat-rate compounded option like Luma Health's tirzepatide at $297/month) skips the extra membership fee.
If you're weighing Ro against LillyDirect for Zepbound specifically, it helps to understand upfront that they're not offering two different medications at two different prices — Ro's Zepbound vials are fulfilled through an integration with LillyDirect's own self-pay pharmacy channel, at the same posted price. The real decision is whether you need what Ro adds on top: a prescriber, insurance navigation, and ongoing clinical support.
How Ro and LillyDirect Actually Relate
LillyDirect is Eli Lilly's direct-to-patient self-pay program, selling Zepbound single-dose vials (and more recently KwikPens) at reduced cash pricing to patients with a valid prescription. Ro partnered directly with this channel, meaning a Ro-affiliated provider can write an on-label Zepbound prescription and have it fulfilled at the same LillyDirect self-pay price — with Ro's membership fee added on top for the prescribing and support layer.
This partnership model is worth understanding clearly upfront: Ro isn't creating its own discounted pricing for Zepbound, and it isn't marking up the medication price above what LillyDirect charges directly to patients. Instead, Ro functions as an access point — a way to get a valid prescription and ongoing clinical support if you don't already have a prescriber willing to write one for you directly through LillyDirect's own portal and standard fulfillment system for eligible patients.
This kind of partnership structure isn't unique to Ro either — several other telehealth platforms have similar arrangements with LillyDirect, meaning the core question when evaluating any of them isn't really about the medication price (which stays constant across LillyDirect-affiliated partners regardless of platform) but about what each platform's membership layer specifically adds for your situation.
The Pricing Breakdown
LillyDirect's self-pay vial pricing commonly runs $299/month for the 2.5mg starting dose, $399/month for 5mg, and $449/month for higher therapeutic doses (7.5mg-15mg), provided you refill within the program's specified window. If you access Zepbound through Ro, you'll pay that same medication price, plus Ro's membership fee — commonly around $39-$45 for the first month, then roughly $145-$149/month afterward (lower with an annual prepay option).
In practice, that means a patient with their own prescribing doctor who sends a prescription directly to LillyDirect pays only the medication cost. A patient going through Ro pays the same medication cost plus the membership fee, in exchange for a prescriber, insurance-coverage checking, and ongoing clinical support.
Running the actual numbers over a full year makes the gap concrete: at the 5mg dose, direct LillyDirect access costs $4,788/year in medication alone. Going through Ro at that same dose adds roughly $1,740-$1,788/year in membership fees on top (assuming standard monthly billing), bringing the combined total to somewhere around $6,528-$6,576/year — a meaningful premium specifically for the prescribing and support layer, not for the medication itself, which is priced identically either way.
If you don't currently have a doctor willing to prescribe Zepbound, or you want help checking whether your insurance actually covers it (a free tool some platforms offer catches coverage many patients don't realize they have), the membership fee is buying real value: access to a prescriber and support you'd otherwise need to find elsewhere. If you already have both, the membership fee is a cost with no corresponding benefit for your specific situation.
The Alternative: Finding Your Own LillyDirect-Eligible Prescriber
Before assuming Ro's membership fee is necessary, it's worth checking whether your existing primary care provider, or another telehealth provider you already have a relationship with, is willing to write a Zepbound prescription that can be filled through LillyDirect directly. Many primary care physicians are comfortable prescribing GLP-1 medications for appropriate patients, and if yours is, you may be able to access LillyDirect's self-pay pricing without any additional membership layer at all.
If you don't have an existing prescriber relationship, a one-time telehealth consultation specifically to obtain a Zepbound prescription (rather than an ongoing membership) may be available through some platforms, which could be a lower-cost path than Ro's recurring membership fee if ongoing insurance-navigation support isn't something you specifically need. Ask any telehealth platform directly whether a single-visit prescription option exists separate from their standard subscription model, since this isn't always prominently advertised even when it's technically available to interested patients who ask.
It's worth being realistic about the tradeoff here: a one-time consultation typically doesn't include the ongoing dose-management support, side-effect troubleshooting, and insurance-navigation help that a membership provides. If you expect to need that ongoing support at any point during your treatment, the membership fee may end up paying for itself in convenience and clinical continuity, even if it looks like an avoidable cost on a purely line-item basis at the outset of your enrollment.
A Third Path: Flat-Rate Compounded Tirzepatide
If your priority is the lowest predictable monthly cost with a prescriber included, it's worth comparing both of these paths against flat-rate compounded tirzepatide as well. Luma Health's compounded tirzepatide is $297/month, flat, regardless of dose — which means as your dose increases toward the 7.5mg-15mg range, the comparison against LillyDirect's rising dose-tiered pricing (or Ro's membership-plus-medication total) can shift in either direction depending on your specific dose and situation. It's worth running the actual math for your expected maintenance dose before deciding.
At the highest LillyDirect dose tier ($449/month for the medication alone), compounded tirzepatide's $297/month flat rate is meaningfully lower, even before adding any membership fee for a prescriber. At the lowest starting dose ($299/month), the comparison is closer, and whether compounded tirzepatide is actually cheaper depends on whether you're comparing against LillyDirect alone or LillyDirect-plus-Ro's-membership.
The tradeoff, as with any compounded-versus-brand comparison, is that compounded tirzepatide isn't itself an FDA-approved finished product, though its active ingredient is the same as the FDA-approved Zepbound formulation prescribed through LillyDirect or a doctor's office. For patients specifically prioritizing the FDA-approved finished product regardless of cost, this tradeoff won't be acceptable; for patients prioritizing lowest predictable cost with a real medical evaluation included as standard, it's a legitimate and increasingly common path chosen by many cash-pay patients.
Insurance Coverage and Regional Availability
Neither LillyDirect's self-pay program nor Ro's membership-based access requires insurance, but if you do have commercial insurance that covers Zepbound, both paths become less relevant compared to simply using your insurance benefit with the manufacturer's separate commercial savings card, which can bring your cost down to as little as $25/month for eligible patients. LillyDirect and the savings card are structurally different programs — LillyDirect is specifically for cash-pay patients without applicable coverage, while the savings card requires existing insurance coverage of the medication itself.
Availability of LillyDirect itself has also expanded since its initial launch, though it's worth confirming current availability and specific terms directly, since manufacturer self-pay programs have adjusted their terms multiple times as the broader GLP-1 market and manufacturing capacity have evolved. What applied a year ago may not reflect the current program structure exactly, so checking directly before making a decision is worthwhile regardless of which path you're leaning toward.
Switching Between These Paths Later
If you start on one path and later want to switch — for example, moving from Ro's membership to your own independent LillyDirect access once you've established a relationship with a primary care provider — this transition is generally straightforward from a medical standpoint, since the medication itself doesn't change. What changes is simply who is writing your prescription and managing your ongoing care relationship going forward.
If you're canceling Ro specifically to pursue independent LillyDirect access, time your cancellation carefully so you have your new prescriber lined up and ready before your Ro membership lapses, to avoid an unnecessary gap in your prescription renewal timeline. LillyDirect itself doesn't manage the prescribing relationship — it fulfills prescriptions written by a licensed provider, so you'll always need some prescribing relationship in place regardless of which specific path you choose to pursue long-term.
Which Path Fits You
The right choice depends heavily on whether you already have a prescriber relationship and how much you value having insurance-navigation support layered on top of the same LillyDirect medication pricing.
- Already have a doctor willing to prescribe Zepbound
- Specifically want the FDA-approved brand product
- Don't need insurance-navigation help or ongoing coaching
- Don't currently have a prescriber for Zepbound or tirzepatide
- Want insurance coverage checked before committing to cash-pay
- Would rather have flat pricing that doesn't rise with dose (compounded route)
A prescriber included,
flat pricing at every dose
Compounded tirzepatide at $297/month — medical evaluation, provider visits, and shipping all included, with pricing that doesn't change as your dose increases.
Get Started → Or start your free health assessmentFrequently Asked Questions
The medication itself is the same price either way, since Ro's Zepbound is fulfilled through the LillyDirect self-pay channel. Going directly through LillyDirect with your own prescriber skips Ro's separate membership fee.
Yes. LillyDirect requires a valid Zepbound prescription from a licensed healthcare provider, whether that's your own doctor, an obesity specialist, or a telehealth provider like Ro.
Provider consultations, ongoing messaging access, insurance-coverage checking, and coordination — the clinical and support layer wrapped around access to the same LillyDirect-priced medication.
It depends on your dose. Flat-rate compounded pricing (like Luma Health's $297/month regardless of dose) can be more or less competitive than LillyDirect's rising dose-tiered pricing depending on where your maintenance dose lands — worth comparing directly for your specific situation.
No. LillyDirect's self-pay pricing is a cash-only program and cannot be combined with insurance or the manufacturer's separate commercial savings card.
To maintain LillyDirect's reduced self-pay pricing at higher doses, refills generally need to be completed within a specified window (commonly 45 days) of the previous delivery. Missing that window can mean paying a higher price until you re-enroll.
Yes, if your existing prescriber is willing to write the prescription. Many primary care physicians will do this for appropriate patients, letting you access LillyDirect pricing without any additional membership fee.
At the 5mg dose, roughly $6,528-$6,576/year combined (medication plus membership), compared to $4,788/year for LillyDirect medication alone — a premium of $1,740-$1,788/year specifically for the prescribing and support layer.
No, compounded tirzepatide isn't itself an FDA-approved finished product, though its active ingredient is the same as Zepbound's. This is a real regulatory distinction worth understanding before choosing that path.
Yes. If your commercial insurance covers Zepbound, using that coverage with the manufacturer's savings card can bring cost to as little as $25/month, potentially undercutting both cash-pay paths entirely.
References
- Eli Lilly and Company. Zepbound (tirzepatide) cost and self-pay information. Lilly.com. 2026. pricinginfo.lilly.com
- Ro. Weight loss program pricing. Ro.co. 2026. Ro.co
- U.S. Food and Drug Administration. Prescribing Information for Zepbound (tirzepatide). FDA.gov. 2025. FDA.gov
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PubMed 35658024